Cotellic (Cobimetinib) in Québec
COBIMETINIB: in association with vemurafenib, for first-line or second-line treatment following a failure with cytotoxic chemotherapy or with immunotherapy targeting the PD-1 or the CTLA-4, of an unresectable or metastatic...
Read More